4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions

Alzheimer's Association International Conference 2026

July 12-15, 2026 | London, United Kingdom, and Online

366

Baicalin And Caffeic Acid Target CLK1 To Mitigate Tau Hyperphosphorylation In Alzheimer’s Disease

View Poster Contact Presenter

Poster Presenter

ANAS SHAMSI

Authors

Anas Shamsi, Sumaiya Khan, Asimul Islam

Affiliations

Center of Medical and Bio-Allied Health Sciences Research, Ajman University, Center for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India

Part of Topic

Baicalin and caffeic acid are novel CLK1 inhibitors.

CLK1 inhibition reduces tau-associated toxicity.

Natural compounds show promise for Alzheimer's disease therapy.

Comments

Email is required but is not shown publicly.

Sort comments

Loading comments...

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.